Opus Medical Pty
Opus designs and manufactures medical devices for use in motion management during cancer treatment Products include the BreatheWell device.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| N/A | $1.3m | Grant | |
| Total Funding | 000k | ||
Related Content
Opus Medical is a Sydney-based healthtech startup specializing in advanced cancer treatment technologies. The company operates in the healthcare sector, focusing on providing innovative solutions for radiotherapy. Its flagship product, Breathe Well, offers a markerless, wireless system that delivers real-time visual feedback and intuitive breathing instructions to patients undergoing deep inspiration breath hold (DIBH) treatments. This technology aims to enhance patient compliance and streamline treatment processes by eliminating the need for physical markers or surrogates. Opus Medical primarily serves healthcare providers and cancer treatment centers, offering a solution that reduces the risk of radiation-induced heart damage during breast cancer treatments. The company generates revenue through the sale and licensing of its Breathe Well system, as well as through ongoing support and maintenance services. Opus Medical has secured significant funding, including over $8 million from the NSW Department of Health and $1.3 million from the MDF, to support its expansion and manufacturing efforts.
Keywords: healthtech, cancer treatment, radiotherapy, DIBH, markerless technology, patient compliance, real-time feedback, breast cancer, Sydney startup, medical device.